Pulse Entdecken nav.journalClub Debatten Trends Forschende

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Start Entdecken nav.journalClub Trends

⌘+K

Shuai-Xing An | Synapse

SA

Shuai-Xing An

Cancer Immunotherapy and Biomarkers

Tianjin Energy Investment Group (China)

About

Research focus

Cancer Immunotherapy and Biomarkers

Impact

1 pubs · 16 cites · h-index 1

Affiliations

Work Experience

Tianjin Energy Investment Group (China)

2024 - 2024

Ministry of Education

2024 - 2024

China Medical University

2024 - 2024

Publications